Advertisement SAFC to expand manufacturing facility in Scotland - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SAFC to expand manufacturing facility in Scotland

SAFC will expand its manufacturing capacity at its facility in Irvine, Scotland, to include large-scale production of bulk dry powder media and reagents.

According to the firm, the expansion, which aims to fulfil the growing needs of the European and Asia Pacific markets, will complement its existing dry powder media facility in Lenexa, Kansas,US.

Under the expansion plans, SAFC will construct a purpose-built Animal Component Free (ACF) dry powder media manufacturing facility to complement the existing liquid cell culture media, buffers, and reagents capabilities in Irvine.

The facility expansion will also include additional raw material and finished goods warehousing as part of the new manufacturing capability.

The firm claims that the new plan aims to complement with appropriate US FDA and EU cGMP requirements and comply with local requirements with regard to safety and environmental regulations.

SAFC President Gilles Cottier said the company will remain committed to investing in areas where it can deliver measurable value to its global customer base.

"These investments and subsequent customer benefits continue to set SAFC apart as a supplier of choice in the industry," Cottier added.

"We are grateful to Scotland’s First Minister, Alex Salmond, and Scottish Enterprise for their support with this expansion in Scotland."